Nirma Khatri Vadlamudi, Ph.D., M.P.H.
Assistant Professor
Department:
Pharmaceutical Outcomes & Policy
Business Phone:
(352) 273-8502
Business Email:
nvadlamudi@ufl.edu
Publications
Academic Articles
2024
Systematic review and meta-analysis of recombinant herpes zoster vaccine in immunocompromised populations.
PloS one.
19(11)
[DOI] 10.1371/journal.pone.0313889.
[PMID] 39585863.
2023
Figure Correction: Using Social Media to Help Understand Patient-Reported Health Outcomes of Post-COVID-19 Condition: Natural Language Processing Approach.
Journal of medical Internet research.
25
[DOI] 10.2196/55010.
[PMID] 38064711.
2023
Pediatric RSV-Associated Hospitalizations Before and During the COVID-19 Pandemic.
JAMA network open.
6(10)
[DOI] 10.1001/jamanetworkopen.2023.36863.
[PMID] 37792376.
2023
Strategies to Prevent Early and Late-Onset Group B Streptococcal Infection via Interventions in Pregnancy.
Pathogens (Basel, Switzerland).
12(2)
[DOI] 10.3390/pathogens12020229.
[PMID] 36839501.
2023
The association of SARS-CoV-2 infection and tuberculosis disease with unfavorable treatment outcomes: A systematic review.
PLOS global public health.
3(7)
[DOI] 10.1371/journal.pgph.0002163.
[PMID] 37467225.
2023
The Impact of Mask Mandates on Face Mask Use During the COVID-19 Pandemic: Longitudinal Survey Study.
JMIR public health and surveillance.
9
[DOI] 10.2196/42616.
[PMID] 36446134.
2023
Using Social Media to Help Understand Patient-Reported Health Outcomes of Post-COVID-19 Condition: Natural Language Processing Approach.
Journal of medical Internet research.
25
[DOI] 10.2196/45767.
[PMID] 37725432.
2022
A population-based analysis to determine the impact of the 13-valent pneumococcal conjugate vaccine on community-acquired pneumonia in British Columbia, Canada.
Vaccine.
40(7):1047-1053
[DOI] 10.1016/j.vaccine.2021.12.065.
[PMID] 35012778.
2022
Healthcare Costs for Pneumococcal Disease in the Era of Infant Immunization With 13-Valent Pneumococcal Conjugate Vaccine: A Population-Based Study.
Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research.
25(9):1510-1519
[DOI] 10.1016/j.jval.2022.03.017.
[PMID] 35466049.
2022
Immunogenicity and Safety of the COVID-19 Vaccines Compared With Control in Healthy Adults: A Qualitative and Systematic Review.
Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research.
25(5):717-730
[DOI] 10.1016/j.jval.2021.09.003.
[PMID] 35500945.
2021
Impact of the 13-valent pneumococcal conjugate vaccine on acute otitis media and acute sinusitis epidemiology in British Columbia, Canada.
The Journal of antimicrobial chemotherapy.
76(9):2419-2427
[DOI] 10.1093/jac/dkab167.
[PMID] 34021757.
2020
Incidence of invasive pneumococcal disease after introduction of the 13-valent conjugate pneumococcal vaccine in British Columbia: A retrospective cohort study.
PloS one.
15(9)
[DOI] 10.1371/journal.pone.0239848.
[PMID] 32997698.
2020
Risk Factors for Herpes Zoster Infection: A Meta-Analysis.
Open forum infectious diseases.
7(1)
[DOI] 10.1093/ofid/ofaa005.
[PMID] 32010734.
2020
The protective effect of pneumococcal vaccination on cardiovascular disease in adults: A systematic review and meta-analysis.
International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases.
99:204-213
[DOI] 10.1016/j.ijid.2020.07.038.
[PMID] 32735953.
2019
Efficacy and Safety of the Pneumococcal Conjugate-13 Valent Vaccine in Adults.
Aging and disease.
10(2):404-418
[DOI] 10.14336/AD.2018.0512.
[PMID] 31011485.
2019
Immunogenicity and safety of the 13-valent pneumococcal conjugate vaccine compared to 23-valent pneumococcal polysaccharide in immunocompetent adults: A systematic review and meta-analysis.
Vaccine.
37(8):1021-1029
[DOI] 10.1016/j.vaccine.2019.01.014.
[PMID] 30685252.
2019
Impact of the 13-Valent Pneumococcal Conjugate Vaccine Among Adults: A Systematic Review and Meta-analysis.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
69(1):34-49
[DOI] 10.1093/cid/ciy872.
[PMID] 30312379.
2017
The Role of Noncomparative Evidence in Health Technology Assessment Decisions.
Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research.
20(10):1245-1251
[DOI] 10.1016/j.jval.2017.06.015.
[PMID] 29241883.
Contact Details
Phones:
- Business:
- (352) 273-8502
Emails:
- Business:
- nvadlamudi@ufl.edu
Addresses:
- Business Mailing:
-
PO Box 100486
1225 CENTER DR
GAINESVILLE FL 32610 - Business Street:
-
1225 CENTER DR
GAINESVILLE FL 32610